Ranitidine Injection Shortage

• • Zantac solution for injection, Teligent, 25 mg/mL, 2 mL vial, 1 count, NDC 52565-0101-10 - discontinued
  • Zantac solution for injection, Teligent, 25 mg/mL, 40 mL vial, 1 count, NDC 52565-0096-01 - discontinued
  • Zantac solution for injection, Teligent, 25 mg/mL, 6 mL vial, 1 count, NDC 52565-0102-01 - discontinued
  • Ranitidine solution for injection, Mylan Institutional, 25 mg/mL, 2 mL vial, 10 count, NDC 67457-0397-99 - discontinued
  • Ranitidine solution for injection, Mylan Institutional, 25 mg/mL, 6 mL vial, 1 count, NDC 67457-0398-62 - discontinued
  • Ranitidine solution for injection, Zydus, 25 mg/mL, 2 mL vial, 10 count, NDC 68382-0422-02 - discontinued
  • Ranitidine solution for injection, Zydus, 25 mg/mL, 40 mL bulk vial, 1 count, NDC 70710-1550-01 - discontinued
  • Ranitidine solution for injection, Zydus, 25 mg/mL, 6 mL vial, 1 count, NDC 68382-0423-06 - discontinued

• • FDA requested all ranitidine presentations, including injectables, are to be withdrawn from the market. More information can be found at: https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market.

• • There are no presentations available

Estimated Resupply Dates

• • All presentations are to be withdrawn from the market.